Treace Medical Concepts (TMCI) Operating Leases (2022 - 2026)

Treace Medical Concepts' Operating Leases history runs 5 years deep, the most recent figure standing at $13.6 million for Q1 2026.

• Quarterly Operating Leases fell 2.57% year-over-year to $13.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.6 million (down 2.57% YoY) and the FY2025 annual result came in at $14.0 million, down 12.25% from the prior year.
• Operating Leases was $13.6 million for Q1 2026 at Treace Medical Concepts, down from $14.0 million in the prior quarter.
• Across five years, Operating Leases topped out at $19.0 million in Q3 2022 and bottomed at $12.9 million in Q3 2025.
• A 5-year average of $15.6 million and a median of $15.9 million in 2023 frame the typical range for Operating Leases.
• Annual changes were most pronounced in 2024 — Operating Leases increased 4.65% — and 2025, when it dropped 21.57%.
• Treace Medical Concepts' Operating Leases stood at $15.5 million in 2022, then climbed by 2.27% to $15.9 million in 2023, then increased by 0.27% to $15.9 million in 2024, then fell by 12.25% to $14.0 million in 2025, then fell by 3.08% to $13.6 million in 2026.
• Business Quant data shows TMCI's Operating Leases at $13.6 million in Q1 2026, $14.0 million in Q4 2025, and $12.9 million in Q3 2025.